The Medicines design research theme is composed of dedicated members with strong expertise and pioneering projects in drug design and delivery.
We combine specialised disciplines in medicinal chemistry, chemical biology, immuno-oncology, regenerative medicine, microbiology, epithelial and skin cell biology, photobiology and pharmaceutics to design and evaluate innovative drugs. These drugs include biosensors, biologics, antimicrobials, anti-ageing, anti-cancers and other therapeutic medicines with the potential for global impact across healthcare.
We also lead cutting-edge projects in medicines design and optimisation of topical (skin and nail) and orally inhaled and nasal drug products as well as prediction of oral and topical drug absorption.
Skin cells taken from patients with a rare genetic disorder are up to ten times more sensitive to damage from ultraviolet A (UVA) radiation in laboratory tests.
Reports from cannabis users that the drug reduces the symptoms of inflammatory bowel disease (IBD) may be explained by new research from Medicine Design Scientists the University of Bath.